![Mestag tx.png 2](https://www.bioindustry.org/static/82addbd0-c3d0-40e2-9fd3357534a7beac/jobdetailscompanylogo_dd64811c02712599828cc4c462858531_4a7c7e45a350/Mestag-tx.png)
Mestag Therapeutics Limited
Our founding investigators comprise global experts in inflammatory disease, cancer, computational biology and fibroblast biology from the University of Oxford, Brigham & Women’s Hospital, Harvard Medical School and Cold Spring Harbor Laboratory. We are supported by leading life science investors SV Health Investors, Johnson & Johnson Innovation – JJDC, Inc., Forbion, GV (formerly Google Ventures) and Northpond Ventures.
Mestag is headquartered in Cambridge, UK, and in 2021 was recognized on the Fierce 15 list of innovative biotechnology companies.